After receiving one of a dwindling number of COVID-era FDA emergency authorizations earlier this year, BD has converted its combination respiratory virus test to a full regulatory green light. The ...
We are maintaining our $306 fair value estimate for narrow-moat Becton, Dickinson as we update our model following fiscal third-quarter results and updated full-year guidance. BD increased its revenue ...
FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results